Transforming lives with rare disease care
Sobi (sobi.com) scores 89 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 97th percentile of 5328 Healthcare brands.
Sobi is a Swedish biopharmaceutical company founded in 2010 and headquartered in Stockholm. It specializes exclusively in rare diseases, developing and providing innovative treatments aimed at improving the lives of affected patients. Sobi operates internationally, serving patients, families, healthcare providers, and the broader medical and scientific community. The company emphasizes expanding access to therapies for conditions that largely lack approved treatments, positioning itself as a global leader in this niche healthcare category.
| Brand Name | Sobi |
|---|---|
| Domain | sobi.com |
| Industry | Healthcare |
| Founded | 2010 |
| Headquarters | Stockholm |
| Main Competitors | BioMarin Pharmaceutical (84/100), Alexion Pharmaceuticals (87/100), Ultragenyx Pharmaceutical (79/100), CSL Behring (87/100), Sanofi (90/100), Takeda Pharmaceutical (87/100) |
Moz Domain Authority 52/100 vs category average 39 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #276,732 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Sobi has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. Learn more about us here." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, og:title, og:description, og:image, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on LinkedIn, YouTube, X (Twitter), Facebook, Instagram, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Sobi?", Claude could identify the brand as of August 2026. Sobi (Swedish Orphan Biovitrum) is a Swedish biopharmaceutical company focused on rare diseases, developing and marketing treatments in areas like hemophilia, immunology, and other rare hematological and inflammatory conditions. Best known for Rare disease and hemophilia treatments, including products like Elocta and Alprolix.
When asked "Best brands similar to Sobi?", Claude would recommend Sobi as of August 2026. It's a well-established specialist in rare diseases and hemophilia, so it's relevant when discussing niche biopharma companies in that space.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Sobi's main competitors in Healthcare: BioMarin Pharmaceutical (84/100), Alexion Pharmaceuticals (87/100), Ultragenyx Pharmaceutical (79/100), CSL Behring (87/100), Sanofi (90/100).
Sources: Brand Analyzer scan
Sobi is a specialised international biopharmaceutical company based in Stockholm, Sweden, founded in 2010. It focuses exclusively on developing and providing treatments for rare diseases.
Sources: Sobi official site
Sobi has moderate AI-search visibility, scoring 65/100 on Brand Analyzer's AI visibility composite (visibility 70, trust 52, recommendation 70). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Sobi official site
Sobi was founded in 2010. Sobi operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Sobi is headquartered in Stockholm. Sobi operates in the Healthcare category.
Sources: Wikidata
Sobi develops and provides innovative biopharmaceutical treatments for people with rare diseases. The company builds a pipeline of medicines targeting conditions where, according to Sobi, only about 5% currently have approved treatments, and works to expand global access to these therapies.
Sources: Sobi official site
Sobi scores 70/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Sobi official site
Sobi can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Sobi official site
Sobi's offerings are used by patients and families affected by rare diseases, prescribed and administered by healthcare providers, and engaged with by the broader medical and scientific community involved in rare disease research and treatment.
Sources: Sobi official site
Sobi is known for its exclusive focus on rare diseases within the biopharmaceutical industry, positioning itself as a global leader dedicated to transforming the everyday lives of patients through innovative treatments and expanded access to therapies.
Sources: Sobi official site
Sobi scores 65/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Sobi has a moderate AI-visibility profile at 65/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (70/100) and its weakest is trust (52/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #276,732 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Sobi from memory (August 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Sobi: Sittercity (89/100), Scope (89/100), Specsavers (89/100), Spring Health (89/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.